Bernard wore a dapper gray suit that matched his graying hair; his profile was sharp and handsome. He closely resembled Leonard Bernstein; it was easy to see why the press had accorded him so much coverage. He was a pioneer—and photogenic, besides. “We keep very tight security here. It’s the court decisions of the last ten years, you know. They’ve been absolutely insane. Losing patent rights because of simply mentioning work being done at a scientific conference. That sort of thing. What else can we expect when the judges are so ignorant of what’s really happening?” The question seemed rhetorical. Edward nodded politely and obeyed Bernard’s hand gesture to climb a flight of steel stairs to the second floor.
“You’ve seen Vergil recently?” Bernard asked as he unlocked room 245.
“Yesterday.”
Bernard entered ahead of him and turned on the lights. The room was barely ten feet square, furnished with a round table and four chairs and a blackboard on one wall. Bernard closed the door. “Sit, please.” Edward pulled out a chair and Bernard sat opposite him, putting his elbows on the table. “Ulam is brilliant. And I won’t hesitate to say, courageous.”
“He’s my friend. I’m very worried about him.”
Bernard held up one finger. “Courageous—and a bloody damned fool. What’s happening to him should never have been allowed. He may have done it under duress, but that’s no excuse. Still, what’s done is done. You know everything, I take it.”
“I know the basics,” Edward said. “I’m still not clear on how he did it.”
“Nor are we, Dr. Milligan. That’s one of the reasons we’re offering him a lab again. And a home, while we sort this out.”
“He shouldn’t be in public,” Edward said.
“No, indeed. We’re constructing an isolation lab right now. But we’re a private company and our resources are limited.”
“This should be reported to the NIH and the FDA.”
Bernard sighed. “Yes. Well, we’d stand to lose everything if word leaked out right now. I’m not talking about business decisions—we’d stand to lose the whole biochips industry. The public outcry could be horrendous.”
“Vergil is very sick. Physically, mentally. He may die.”
“Somehow, I don’t think he’ll die,” Bernard said. “But we’re getting away from the focus.”
“What is the focus?” Edward asked angrily. “I assume you’re working hand-in-glove with Genetron now—you certainly talk like you are. What does Genetron stand to gain?”
Bernard leaned back in his chair. “I can think of a large number of uses for small, super-dense computer elements with a biological base. Can’t you? Genetron has already made breakthroughs, but Vergil’s work is something else again.”
“What do you envision?”
Bernard’s smile was sunny and certifiably false. “I’m not really at liberty to say. It’ll be revolutionary. We’ll have to study him in lab conditions. Animal experiments have to be conducted. We’ll have to start from scratch, of course. Vergil’s… um… colonies can’t be transferred. They’re based on his own cells. We have to develop organisms that won’t trigger immune responses in other animals.”
“Like an infection?” Edward asked.
“I suppose there are similarities. But Vergil is not infected or ill in the normal uses of the words.”
“My tests indicate he is,” Edward said.
“I don’t think the usual diagnostics are appropriate, do you?”
“I don’t know.”
“Listen,” Bernard said, leaning forward. “I’d like you to come and work with us once Vergil’s settled in. Your expertise might be useful to us.”
Edward almost flinched at the openness of the offer. “How will you benefit from all this?” he asked. “I mean you, personally.”
“Edward, I have always been at the forefront of my profession. I see no reason why I shouldn’t be helping here. With my knowledge of brain and nerve functions, and the research I’ve been conducting in artificial intelligence and neurophysiology – “
“You could help Genetron hold off a government investigation,” Edward said.
“That’s being very blunt. Too blunt, and unfair.” For a moment, Edward sensed uncertainty and even a touch of anxiety in Bernard.
“Maybe I am,” Edward said. “And maybe that’s not the worst thing that can happen.”
“I don’t get you,” Bernard said.
“Bad dreams, Mr. Bernard.”
Bernard’s eyes narrowed and his brows lowered. Here was an uncharacteristic expression, not suitable for covers on Time, Mega or Rolling Stone: a puzzled and angry scowl. “Our time is too valuable to be wasted. I’ve made the offer in good faith.”
“Of course,” Edward said. “And of course, I’d like to visit the lab when Vergil’s settled in. If I’m still welcome, bluntness and all.”
“Of course,” Bernard echoed, but his thoughts were almost nakedly apparent: Edward would never be playing on his team. They rose together and Bernard held out his hand. His palm was damp; he was as nervous as Edward.
“I assume you want this all in strict confidence,” Edward said.
“I’m not sure we can require it of you. You’re not under contract.”
“No,” Edward said.
Bernard regarded him for a long moment, then nodded. “I’ll escort you out.”
“There’s one more thing,” Edward said. “Do you know anything about a woman named Candice?”
“Vergil mentioned he had a girlfriend by that name.”
“Had, or has?”
“Yes, I see what you mean,” Bernard said. “She could be a security problem.”
“No, that’s not what I mean,” Edward said emphatically. “Not at all what I mean.”
13
Bernard went through the stapled papers carefully, hand on forehead, lifting the legal-sized pages and folding them back, his frown deepening.
What was going on in the black cube was enough to make his hair stand on end. The information was by no means complete, but his friends in Washington had done a remarkable job. The packet had arrived by special courier just half an hour after Edward Milligan left.
Their conversation had filled him with a biting, defensive shame. He saw a distant version of himself in the young doctor, and the comparison hurt. Had good old famous Michael Bernard been walking around in a fog of capitalistic seduction the last few months?
At first, Genetron’s offer had seemed clean and sweet– minimal participation in the first few months, then status as a father-figure and pioneer, his image to be used to promote the company.
It had taken him entirely too long to realize how close he was to the trigger of the trap.
He looked up at the window and stood to raise the blinds. With a rustling snap, he had a clear view of the mound, the black cube, the wind-swept clouds beyond.
He could smell disaster. The black cube, ironically, would not be involved; but if Vergil Ulam had not triggered things, then the other side of Genetron would have done so eventually.
Ulam had been fired so precipitously, and blackballed so thoroughly, not because he had done sloppy research—but because he had followed so closely on the heels of the defense research division. He had succeeded where they had met frequent setbacks and failure. And even though they had studied his files for months (multiple copies had been made) they could not duplicate his results.
Harrison yesterday had murmured that Ulam’s discoveries must have been largely accidental. It was obvious why he would say that now.
Ulam had come very close to taking his success and leaving Genetron, and the government, in the lurch. The Big Boys could not put up with that, and could not trust Ulam.
He was your basic crackpot. He could never have gotten a security clearance.
So they had tossed him out, and frozen him out.